share_log

Baird Maintains Outperform on Longboard Pharmaceuticals, Raises Price Target to $60

Benzinga ·  07:12

Baird analyst Joel Beatty maintains Longboard Pharmaceuticals (NASDAQ:LBPH) with a Outperform and raises the price target from $36 to $60.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment